Loading clinical trials...
Loading clinical trials...
A Cluster-randomised, Open-label Trial to Compare the Impact of Combined Mass Vaccine and Drug Administrations, Mass Drug Administration, Mass Vaccinations, or no Intervention on Plasmodium Falciparum Malaria Transmission
Conditions
Interventions
DHA/piperaquine and a SLD-PQ
Study vaccine R21/Matrix-M™
Locations
2
Bangladesh
Alikadam Upazila Health Complex
Bāndarban, Bangladesh
Lama Upazila Health Complex
Lāma, Bangladesh
Start Date
February 15, 2025
Primary Completion Date
February 1, 2028
Completion Date
February 1, 2028
Last Updated
December 18, 2025
NCT05764746
NCT06549257
NCT03923725
NCT04147546
NCT03996967
NCT03167242
Lead Sponsor
University of Oxford
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions